NCT03699748

Brief Summary

The purpose of the LEAPS program is to understand how a trained lay health worker who engages with newly diagnosed patients after a diagnosis of an advanced stage of cancer can help to engage patients in advance care planning, improve patient satisfaction with their decision-making, activation, quality of life, and healthcare resource utilization.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 5, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 9, 2018

Completed
23 days until next milestone

Study Start

First participant enrolled

November 1, 2018

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2022

Completed
6 months until next milestone

Results Posted

Study results publicly available

July 7, 2023

Completed
Last Updated

July 7, 2023

Status Verified

July 1, 2023

Enrollment Period

3.2 years

First QC Date

October 5, 2018

Results QC Date

January 12, 2023

Last Update Submit

July 6, 2023

Conditions

Keywords

cancerend of lifepatient-centered

Outcome Measures

Primary Outcomes (1)

  • Patient Quality of Life Using the Functional Assessment of Cancer Therapy - General Survey

    Each patient will receive a quality of life survey (Functional Assessment of Cancer Therapy - General Survey) at baseline and 4 months. We will measure the change in quality of life at baseline to 4 months. Scores for quality of life will be assessed using the Functional Assessment of Cancer Therapy - General (FACT-G), a 27-item questionnaire designed to measure four domains of HRQOL in cancer patients: Physical, social, emotional, and functional well-being. Each question is a 5-point likert scale item. Scores range from 0-108. The higher the score, the better the quality of life.

    Change in Quality of Life from Baseline to 4 Months

Secondary Outcomes (28)

  • Patient Satisfaction With Decision-Making Using the Satisfaction With Decision (SWD) Survey

    Proportion of patients who strongly agree that decisions about their health care were theirs to make at 4 months post study enrollment.

  • Patient Satisfaction With Decision-Making Using the Satisfaction With Decision Survey

    Proportion of patients who strongly agree that decisions about their health care were theirs to make at 12 months post study enrollment.

  • Patient Activation Using the Patient Activation Measure Survey

    Change in Patient Activation Measure from baseline to 4 months post enrollment.

  • Patient Activation Using the Patient Activation Measure Survey

    Change in Patient Activation Measure from baseline to 12 months post-enrollment.

  • Patient Quality of Life Using the Functional Assessment of Cancer Therapy - General Survey

    Health-related quality of life at 12 months

  • +23 more secondary outcomes

Study Arms (2)

Intervention Group Arm

EXPERIMENTAL

Patients randomized into the intervention will be assigned a lay health worker who will contact the patient to begin the intervention. The intervention includes: education on early advance care planning, documenting goals of care, assessing symptoms, and coordinating community services (such as home health, home visits, and home hospice). The intervention arm will also receive usual care as provided by Unite Here Health and their local oncologists.

Behavioral: Lay Health Worker InterventionOther: Usual Care

Control Group Arm

ACTIVE COMPARATOR

The control group arm will receive usual care as provided by Unite Here Health and their local oncologists.

Other: Usual Care

Interventions

Patients randomized into the intervention will be assigned a lay health worker who will contact the patient to begin the intervention. The intervention includes: education on early advance care planning, documenting goals of care, assessing symptoms, and coordinating community services (such as home health, home visits, and home hospice). The intervention is provided along with usual care as provided by Unite Here Health and local oncologists.

Intervention Group Arm

Usual care as provided by Unite Here Health and local oncologists

Control Group ArmIntervention Group Arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Newly diagnosed patients with a cancer diagnosis.
  • Patients with any relapse or progressive disease (any cancer diagnosis) as identified by imaging or biopsy and confirmed by physician.
  • The patients must be 18 years or older.
  • Patients must have the capacity to verbally consent.

You may not qualify if:

  • Inability to consent to the study due to lack of capacity as documented by the referring physician.
  • Patients without a newly diagnosed malignancy or patients without relapse of disease.
  • Patients not eligible for Fund benefits.
  • Patients without a newly diagnosed malignancy or patients without relapse of disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University School of Medicine

Stanford, California, 94305, United States

Location

Related Publications (2)

  • Patel MI, Kapphahn K, Wood E, Coker T, Salava D, Riley A, Krajcinovic I. Effect of a Community Health Worker-Led Intervention Among Low-Income and Minoritized Patients With Cancer: A Randomized Clinical Trial. J Clin Oncol. 2024 Feb 10;42(5):518-528. doi: 10.1200/JCO.23.00309. Epub 2023 Aug 25.

  • Patel MI, Khateeb S, Coker T. A randomized trial of a multi-level intervention to improve advance care planning and symptom management among low-income and minority employees diagnosed with cancer in outpatient community settings. Contemp Clin Trials. 2020 Apr;91:105971. doi: 10.1016/j.cct.2020.105971. Epub 2020 Mar 4.

MeSH Terms

Conditions

DeathNeoplasms

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr. Manali Patel
Organization
Stanford University

Study Officials

  • Manali I Patel, MD MPH MS

    Stanford University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

October 5, 2018

First Posted

October 9, 2018

Study Start

November 1, 2018

Primary Completion

December 31, 2021

Study Completion

December 30, 2022

Last Updated

July 7, 2023

Results First Posted

July 7, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations